These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6124226)

  • 21. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 22. Paliperidone overdose in a patient with schizophrenia.
    Chang JP; Huang CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588
    [No Abstract]   [Full Text] [Related]  

  • 23. Supersensitivity psychosis.
    Peet M
    J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
    [No Abstract]   [Full Text] [Related]  

  • 24. [The risk of neuroleptic discontinuation in schizophrenia].
    Jarema M
    Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
    Meltzer HY
    Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuroleptic withdrawal in schizophrenic patients.
    Baldessarini RJ; Viguera AC
    Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842
    [No Abstract]   [Full Text] [Related]  

  • 28. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A; Dwolatzky T; Lerner V
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stopping drug treatment in schizophrenia.
    Drug Ther Bull; 1987 Apr; 25(8):31-2. PubMed ID: 2884089
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 31. Tardive dyskinesia as a risk factor for negative symptoms.
    Wright P; Taylor M
    Br J Psychiatry; 1994 May; 164(5):700-1; author reply 702. PubMed ID: 7921731
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 33. Untreated psychosis and long-term outcome in schizophrenia.
    Waddington JL; Scully PJ
    Schizophr Bull; 1998; 24(1):34-5. PubMed ID: 9502545
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse effects of antiparkinson drug withdrawal.
    Jellinek T; Gardos G; Cole JO
    Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clozapine withdrawal. A review].
    Szafrański T; Gmurkowski K
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced depression.
    Lancet; 1977 Dec 24-31; 2(8052-8053):1333-4. PubMed ID: 74737
    [No Abstract]   [Full Text] [Related]  

  • 37. Risks of withdrawing antipsychotic medications.
    Wyatt RJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):205-8. PubMed ID: 7872847
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing clozapine discontinuation - acute and chronic maintenance strategies.
    Shields MK; Bastiampillai T; Mohan T
    Aust N Z J Psychiatry; 2012 Nov; 46(11):1104-5. PubMed ID: 23104931
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses.
    Leblanc G; Cormier H; Gagné MA; Vaillancourt S
    Can J Psychiatry; 1994 May; 39(4):223-9. PubMed ID: 7913872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.